Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
Abstract Background: Breast cancer therapy has been facing remarkable changes. Classic treatments are now combined with other therapies to improve…
Georgina Correia-da-Silva
Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells
Abstract Cannabidivarin (CBDV) and cannabigerol (CBG) are minor phytocannabinoids from Cannabis sativa, whose health benefits have been reported. However, studies…
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
Abstract Simple Summary: Estrogen receptor-positive (ER+) breast cancer is the most prevalent breast cancer subtype, accounting for 70–85% of all…
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
Abstract Although cannabinoids have been used for centuries for diverse pathological conditions, recently, their clinical interest and application have emerged…